Jing Xin Goh, Kamal Sud, Wubshet Tesfaye, Connie Van, Shrey Seth, Surjit Tarafdar, Ronald L Castelino
{"title":"The impact of medication regimen complexity on patient-related and clinical outcomes in kidney failure: a systematic review.","authors":"Jing Xin Goh, Kamal Sud, Wubshet Tesfaye, Connie Van, Shrey Seth, Surjit Tarafdar, Ronald L Castelino","doi":"10.1080/14656566.2025.2450359","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Kidney failure is a life-limiting condition that profoundly impacts an individual's quality of life. The significant medication burden on patients required to manage the comorbidities and complications of kidney failure can have implications for patient-reported and clinical outcomes.</p><p><strong>Methods: </strong>This work systematically reviewed methods used to assess medication regimen complexity amongst adults with kidney failure, the associated patient-reported and clinical outcomes, and the effectiveness of interventions to address regimen complexity. A comprehensive search of PubMed, Embase, Web of Science, and Scopus covering all relevant literature up until November 2023 was performed.</p><p><strong>Results: </strong>The findings of this review suggest that patients with kidney failure are prescribed complex medication regimens, which have implications for both clinical and patient-related outcomes. A significant link was found between regimen complexity and poor health outcomes, particularly in the dialysis-dependent patient population. These outcomes included poor quality of life, medication adherence, frailty, hospitalization, and mortality. Interventions to improve medication regimen complexity included de-prescribing tools and pharmacist-led medication management services.</p><p><strong>Conclusion: </strong>Future research should consider well-designed prospective longitudinal studies that develop more comprehensive and standardized definitions of medication regimen complexity. Additionally, multifaceted interventions are needed to address the complex medication regimen to improve outcomes in patients with kidney failure.</p>","PeriodicalId":12184,"journal":{"name":"Expert Opinion on Pharmacotherapy","volume":" ","pages":"209-217"},"PeriodicalIF":2.5000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Pharmacotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14656566.2025.2450359","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Kidney failure is a life-limiting condition that profoundly impacts an individual's quality of life. The significant medication burden on patients required to manage the comorbidities and complications of kidney failure can have implications for patient-reported and clinical outcomes.
Methods: This work systematically reviewed methods used to assess medication regimen complexity amongst adults with kidney failure, the associated patient-reported and clinical outcomes, and the effectiveness of interventions to address regimen complexity. A comprehensive search of PubMed, Embase, Web of Science, and Scopus covering all relevant literature up until November 2023 was performed.
Results: The findings of this review suggest that patients with kidney failure are prescribed complex medication regimens, which have implications for both clinical and patient-related outcomes. A significant link was found between regimen complexity and poor health outcomes, particularly in the dialysis-dependent patient population. These outcomes included poor quality of life, medication adherence, frailty, hospitalization, and mortality. Interventions to improve medication regimen complexity included de-prescribing tools and pharmacist-led medication management services.
Conclusion: Future research should consider well-designed prospective longitudinal studies that develop more comprehensive and standardized definitions of medication regimen complexity. Additionally, multifaceted interventions are needed to address the complex medication regimen to improve outcomes in patients with kidney failure.
肾衰竭是一种严重影响个人生活质量的限制生命的疾病。管理肾衰竭合并症和并发症所需的患者的重大药物负担可能对患者报告和临床结果产生影响。方法:本工作系统地回顾了用于评估成人肾衰竭患者用药方案复杂性的方法,相关的患者报告和临床结果,以及解决方案复杂性的干预措施的有效性。对PubMed、Embase、Web of Science和Scopus进行了全面的检索,涵盖了截至2023年11月的所有相关文献。结果:本综述的研究结果表明,肾衰竭患者需要复杂的药物治疗方案,这对临床和患者相关的结果都有影响。研究发现,方案复杂性与不良健康结果之间存在显著联系,特别是在依赖透析的患者群体中。这些结果包括生活质量差、药物依从性、虚弱、住院和死亡率。改善药物治疗方案复杂性的干预措施包括取消处方工具和药剂师主导的药物管理服务。结论:未来的研究应考虑设计良好的前瞻性纵向研究,以制定更全面和标准化的药物方案复杂性定义。此外,需要多方面的干预措施来解决复杂的药物治疗方案,以改善肾衰竭患者的预后。
期刊介绍:
Expert Opinion on Pharmacotherapy is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on newly approved/near to launch compounds mainly of chemical/synthetic origin, providing expert opinion on the likely impact of these new agents on existing pharmacotherapy of specific diseases.